Yahoo France Recherche Web

  1. Should you pass or buy Johnson & Johnson? Zacks experts tell all in a free Special Report. Free report pulls back the curtain on what's happening with JNJ. Grab your free copy.

Résultats de recherche

  1. 27 juin 2024 · Johnson & Johnson: Evolution du consensus et de l'objectif de cours des analystes Action Johnson & Johnson | JNJ | US4781601046 | Nyse

  2. 28 juin 2024 · At Johnson & Johnson, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

  3. 1 juil. 2024 · Johnson & Johnson announced in May that it plans to pay nearly $6.5 billion over 25 years to settle all pending and future U.S. lawsuits alleging that its baby powder and other talc-based products ...

  4. 1 juil. 2024 · Sigue la cotización de Johnson & Johnson en directo: acciones, evolución, histórico, dividendos y últimas noticias de Johnson & Johnson y del resto de empresas del mercado en Cinco Días.

  5. Il y a 3 jours · Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  6. 1 juil. 2024 · Trailing Returns. Financials. Valuation. Operating Performance. Dividends. Ownership. Executive. Review the current JNJ dividend history, yield and Johnson and Johnson stock split data to decide ...

  7. 26 juin 2024 · Johnson & Johnson (J&J) has finalised a $700m (£552m; €654m) settlement with 42 US states and the District of Columbia to end their lawsuit alleging that the company knew that its talcum based products, including the iconic Johnson’s Baby Powder, contained asbestos and threatened human health.1 The settlement, which awaits final approval by a judge, still leaves the company facing ...

  1. Recherches liées à johnson & johnson

    vaccin johnson & johnson